- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Resource Center
- PKD & Rare Kidney Diseases
- Anemia Due To CKD
- CKD & Related Comorbid Conditions
- Kidney Failure & Kidney Replacement Therapies
- Electrolyte Disorders
- NephU Nutrition & The NephChefTM
- NephU Presents – Hot Topics in Nephrology
- NephU Med Talks
Kidney transplantation can improve the quality of life and reduces the mortality risk for patients who have reached kidney failure.1 However, there are many considerations that a patient undergoes during the transplant evaluation process, some of which are unique to patients with autosomal dominant polycystic kidney disease (ADPKD). Join us as experts, Dr Meyeon Park and Dr Simin Goral discuss different factors and choices patients with kidney failure must process during their journey to a kidney transplant. As well as hearing from our peer specialist, Mr Kevin Fowler, about his experience during his pre-emptive transplant journey.
- Vella, J. (2019). Kidney transplantation in adults: Patient survival after kidney transplantation.
*Drs Meyeon Park, Simin Goral, and Mr Kevin Fowler are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Jill Green is an employee of OPDC.
If you would like to register for the 6:00 pm to 7:00 pm EDT broadcast, please click below:
Director of the Polycystic Kidney Disease Center of Excellence at the University California San Francisco*
Dr Meyeon Park is a nephrologist who cares for patients affected in various ways by high blood pressure and kidney disease. She has a special focus on polycystic kidney disease (PKD) and directs UCSF’s PKD Center of Excellence. Through her research Dr Park explores how lifestyle changes can provide better outcomes for patients with PKD. Dr Park earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She then completed a residency in internal medicine at the Yale School of Medicine, followed by a fellowship in nephrology at UCSF. She also has a Master of Advanced Study degree in clinical research from UCSF.
Director of the Polycystic Kidney Disease Clinic at the University of Pennsylvania*
Dr Simin Goral is a nephrologist at the Perelman School of Medicine at the University of Pennsylvania. In addition, she is the Director of the Polycystic Kidney Disease Clinic at the University of Pennsylvania as well as Director of the Transplant Nephrology Fellowship Program. Dr Goral received her medical degree from the University of Istanbul. She then completed a residency in internal medicine at the University of Istanbul, followed by a fellowship in nephrology at Vanderbilt University Medical Center. Dr Goral specializes in managing the care for patients with polycystic kidney disease (PKD) as well as ensuring any patient approaching kidney failure receives appropriate care during the kidney transplant evaluation process and throughout the post-kidney transplant journey.
The Voice of The Patient, Inc.*
Kevin Fowler has worked in the pharmaceutical industry for over 25 years. His career has encompassed a breadth and depth of skills and experiences, including positions in sales management, training, public affairs, global marketing, patient advocacy, and patient marketing. In 2014, Kevin formed his own patient advocacy and patient engagement consulting business, “The Voice of the Patient, Inc. And impressively, in 2020 Kevin was invited to be a member of the Kidney Health Initiative, Board of Directors. Aligning his professional skills and personal experiences with having a pre-emptive kidney transplant in 2004, Kevin exemplifies a true leader in patient advocacy and patient engagement.
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Jill A Green, PhD, is a Senior Medical Science Liaison in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.
Dr Green has been a proud member of the PKD Foundation – Columbus, OH chapter for over 12 years where she has been active in fundraising and advocacy efforts.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?May 25 from 12:00 pm to 1:00 pm
Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?May 25 from 9:00 pm to 10:00 pm
June 1 from 12:00 pm to 1:00 pm
- Resource Center
- Presentation Request